Bismarck Bisono presenting @escmid.bsky.social on invasive aspergillosis in patients with chronic lymphocytic leukemia
Pascalis Vergidis, MD
@pascalisid.bsky.social
Infectious Disease physician | Professor at Mayo Clinic | Microbiology Course Director | ABIM Governance Member
Y ou know about invasive aspergillosis in AML. Do you want to learn what happens in Chronic Lymphocytic Leukemia? Dr. Bismarck Bisono will discuss risk factors and outcomes. First presentation in IFI session @escmid.bsky.social
Mary Bowden, MD was fired by her own institution for prescribing ivermectin to treat Covid-19 (among other reasons). She has recently drawn attention for targeting doctors starting their training. We (as medical community) are not obligated to engage with or amplify her posts.
Serofast in syphilis refers to a state where patients have persistently reactive nontreponemal test titers despite successful treatment, without evidence of treatment failure or reinfection.
Department of Medicine Staff Awards @mayocliniccancer.bsky.social Honored to be a Member of the amazing CAR-T cell therapy team.
Mycology Lab for the medical students at Mayo Clinic Alix School of Medicine. We reviewed morphological differences between Aspergillus and Mucorales.
Included in this year’s Mycology Lecture for the medical students at Mayo Clinic Alix School of Medicine. Trichophyton indotinae, an emerging fungal threat
Microbiology course at Mayo Clinic Alix School of Medicine. We reviewed 4 case of tuberculosis with a focus on social determinants of health. Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
Bacteriology Lab for the medical students at Mayo Clinic Alix School of Medicine led by Dr. Bobbi Pritt. We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
Introduction to Microbiology for the medical students at the Mayo Clinic Alix School of Medicine We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
Looking forward to our journal club #MayoClinic Infectious Disease Fellowship. Adjunctive corticosteroids in hypoxemic patients with non-HIV Pneumocystis pneumonia. No difference in 28-day mortality. However, need for mechanical ventilation was lower in the steroid group.
As a member of the ABIM Infectious Disease Approval Committee, I would like to congratulate those who recently passed their Boards. You are all committed to delivering exceptional patient care and upholding the highest standards in Medicine.
How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB <vori=isavu @idweek.bsky.social #IDWeek2025 #TxID #IDSky
Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.
There’s now an app for all things fungi 🦠🍄 Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone. Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
Home - Doctor Fungus
Welcome to Doctor Fungus! An Educational Website of theMycoses Study Group Education and Research Consortium (MSGERC) [View Legal Information] Where to Start Mycology Case of the Month An Introducti...
drfungus.org
🆕 MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time. And nearly 75% of these cases had no long-term care facility link This is a changing landscape of antibiotic resistance - happening across US #IDSky 📄: www.cdc.gov/mmwr/volumes...
Detection of Mucorales antigen in BAL samples using a newly developed lateral-flow device A Mucorales antigen test is sorely needed This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR) journals.asm.org/doi/10.1128/...
Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” June 19 2.55-3.25 pm @ASMicrobiology Dallas Smith @CDCgov Sean Zhang, Fungal Diagnostics Laboratory Consortium Rob Purdie, MYCology Advocacy, Research & Education Zachary Rubin @lapublichealth Me @MSG_ERC
Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee. Of the profession, for the public
Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients. Several patients on concurrent antivirals, which confounded the effectiveness of VSTs @CIDJournal @transplantidnet.bsky.social academic.oup.com/cid/advance-...
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review
Cytomegalovirus-specific T cells have been used in studies of primarily adult hematopoietic stem cell transplant recipients. Heterogenous trial design and
academic.oup.com
Dr. Jeniel Nett discussing biofilm at the 2025 Scientific Meeting on Candida auris @msgerc.bsky.social
High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare. @transplantidnet.bsky.social academic.oup.com/cid/advance-...
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With Human Immunodeficiency Virus in the United States
The prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) was high among kidney donor and transplant recipients with HIV. Posttransplant KSHV-associat
academic.oup.com
In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions @transplantidnet.bsky.social academic.oup.com/cid/advance-...
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
AbstractBackground. We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant imm
academic.oup.com
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024) Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo Jack McHugh ... @pascalisid.bsky.social academic.oup.com/jid/advance-...
This #TransDayofVisibility 🏳️⚧️ Please know: We see you, & we will continue to fight for you.
Clinical Infectious Diseases@cidjournal.bsky.social · last yr.Silence=Death Redux: Infectious Diseases, Public Health, and the Imperative to Resist ✅ Just Accepted ✍️ @ericmeyerowitz.bsky.social @germhuntermd.bsky.social #IDSky
ID Grand Rounds. I discussed the following: - ONE Health - Aspergillus urine antigen - Giant magnetoresistance-enabled PCR - Rezafungin for prevention in bone marrow transplant - Ibrexafungerp (FURI) - Olorofim (Study 32) - Our experience with fosmanogepix
In rare cases, vaping-associated lung injury (EVALI) may lead to irreversible damage requiring lung transplantation
We used Giant Magnetoresistance to diagnose invasive fungal infection. The assay has the potential to detect trace amounts of fungal DNA in serum academic.oup.com/ofid/article...
A Novel Giant Magnetoresistance–Enabled Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Invasive Fungal Infection
AbstractBackground. Despite advances in clinical microbiology, the diagnosis of invasive fungal infections remains challenging. Giant magnetoresistance (GM
academic.oup.com